AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24014828 — intervention group
Group type: COMPARATOR
Intervention: CRT
Number of subjects: 608
Study 21724564 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (loading dose 1 g over 10 minutes, then infusion of 1 g over 8 hours)
Number of subjects: 270
Study 21724564 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 21724564 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 270
Study 20012799 — intervention group
Group type: EXPERIMENTAL
Intervention: Two servings of dairy products/day
Number of subjects: 120
Study 20012799 — intervention group
Group type: EXPERIMENTAL
Intervention: Three servings of dairy products/day
Number of subjects: 120
Study 20012799 — intervention group
Group type: EXPERIMENTAL
Intervention: Four servings of dairy products/day
Number of subjects: 120
Study 20012799 — intervention group
Group type: COMPARATOR
Intervention: Calorie restricted diet (control group)
Number of subjects: 120
Study 17704496 — intervention group
Group type: EXPERIMENTAL
Intervention: Endarterectomy
Number of subjects: 527
Study 17704496 — intervention group
Group type: COMPARATOR
Intervention: Stenting
Number of subjects: 527
Study 15848673 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete steroid avoidance (standard therapy without steroid induction/maintenance)
Number of subjects: 72
Study 15848673 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (tacrolimus, mycophenolate mofetil, steroid induction/maintenance)
Number of subjects: 72
Study 15848673 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete steroid avoidance
Number of subjects: 72
Study 15848673 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 72
Study 11999667 — intervention group
Group type: EXPERIMENTAL
Intervention: BH4 (1 mg/min)
Number of subjects: 28
Study 11999667 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 28
Study 10464738 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorzolamide 2%
Number of subjects: 122
Study 10464738 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study 8672316 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine 1 ml kg‐1 with ketamine 0.5 mg kg‐1
Number of subjects: 60
Study 8672316 — intervention group
Group type: COMPARATOR
Intervention: 0.25% bupivacaine 1 ml kg‐1 with clonidine 2 micrograms kg‐1
Number of subjects: 60
Study 8672316 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine 1 ml kg‐1 with adrenaline 5 micrograms ml‐1 (1/200,000)
Number of subjects: 60
Study 2189288 — intervention group
Group type: COMPARATOR
Intervention: CMF
Number of subjects: 49
Study 2189288 — intervention group
Group type: EXPERIMENTAL
Intervention: CMF + T
Number of subjects: 49
Study 23973 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxypertine 30 mg daily
Number of subjects: 0
Study 23973 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxypertine 60 mg daily
Number of subjects: 0
Study 23973 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 0
Study 29799307 — intervention group
Group type: EXPERIMENTAL
Intervention: Triflo II (TF)
Number of subjects: 14
Study 29799307 — intervention group
Group type: EXPERIMENTAL
Intervention: Diaphragmatic breathing (DB)
Number of subjects: 14
Study 29799307 — intervention group
Group type: EXPERIMENTAL
Intervention: Water pressure threshold device (BreatheMAX; BM)
Number of subjects: 14
Study 27470500 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based humanistic counselling (SBHC)
Number of subjects: 64
Study 27470500 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 64
Study 25879932 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT) delivered by psychologists with usual care
Number of subjects: 246
Study 25879932 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 246
Study 23927194 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 kHz ultrasound for 15 min
Number of subjects: 20
Study 23927194 — intervention group
Group type: COMPARATOR
Intervention: 20 kHz ultrasound at 100 mW/cm(2)
Number of subjects: 20
Study 20569223 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous sodium valproate, loading dose of 900-1200 mg
Number of subjects: 36
Study 19159881 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 17383335 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 250
Study 17383335 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 250
Study 14963702 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DEX) 0.3 mg/kg per day for 3 days + 2 g/kg IVIG over 4 to 5 days
Number of subjects: 46
Study 14963702 — intervention group
Group type: COMPARATOR
Intervention: Control group: 2 g/kg IVIG over 4 to 5 days + higher dose acetylsalicylic acid
Number of subjects: 46
Study 11588947 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 mg transdermal estradiol twice weekly
Number of subjects: 159
Study 11588947 — intervention group
Group type: COMPARATOR
Intervention: 0.625 mg oral conjugated estrogen daily with 2.5 mg oral medroxyprogesterone acetate daily
Number of subjects: 159
Study 11588947 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal therapy
Number of subjects: 159
Study 11588947 — intervention group
Group type: COMPARATOR
Intervention: Oral treatment
Number of subjects: 159
Study 9973671 — intervention group
Group type: EXPERIMENTAL
Intervention: Brisk walking intervention (20.4 +/- 3.9 min/day for 1 year)
Number of subjects: 69
Study 9973671 — intervention group
Group type: COMPARATOR
Intervention: Control group (bb genotype)
Number of subjects: 69
Study 7798545 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine 0.1% (1 spray [0.12 mg] per nostril every 12 hours, 2 sprays per nostril every 12 hours, or 2 sprays per nostril once daily)
Number of subjects: 264
Study 7798545 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine maleate (12 mg twice daily)
Number of subjects: 264
Study 7798545 — intervention group
Group type: COMPARATOR
Intervention: Placebo (twice daily)
Number of subjects: 264
Study 2647645 — intervention group
Group type: EXPERIMENTAL
Intervention: reserpine, prazosin, indapamide, atenolol (separately or in combination)
Number of subjects: 80
Study 2647645 — intervention group
Group type: COMPARATOR
Intervention: prazosin
Number of subjects: 80
Study 825133 — intervention group
Group type: EXPERIMENTAL
Intervention: Methaqualone hydrochloride (400 mg)
Number of subjects: 1
Study 825133 — intervention group
Group type: EXPERIMENTAL
Intervention: Methaqualone (20 and 30 mg/kg body weight) in monkeys
Number of subjects: 1
Study 31403168 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive and behavioral therapy for insomnia (CBT-i)
Number of subjects: 145
Study 31403168 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 145
Study 29095305 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct intramuscular injection of MSCs (1*10 cells in 1 mL of 0.9% saline)
Number of subjects: 120
Study 29095305 — intervention group
Group type: COMPARATOR
Intervention: Placebo-controlled group (1 mL of 0.9% saline)
Number of subjects: 120
Study 26465872 — intervention group
Group type: EXPERIMENTAL
Intervention: Statins + Amlodipine + Renin-Angiotensin-Aldosterone System Inhibitors (Benazepril or Losartan)
Number of subjects: 0
Study 26465872 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine + Renin-Angiotensin-Aldosterone System Inhibitors (Benazepril or Losartan) without Statins
Number of subjects: 0
Study 23622070 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 110
Study 23622070 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine pediatric care + OMT
Number of subjects: 110
Study 23622070 — intervention group
Group type: COMPARATOR
Intervention: Routine pediatric care
Number of subjects: 110
Study 21786539 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity PRI training
Number of subjects: 30
Study 21786539 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity PRI training
Number of subjects: 30
Study 21786539 — intervention group
Group type: COMPARATOR
Intervention: Traditional training
Number of subjects: 30
Study 19190515 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigational arm (first-line chemotherapy)
Number of subjects: 23457
Study 19190515 — intervention group
Group type: COMPARATOR
Intervention: Reference arm (first-line chemotherapy)
Number of subjects: 23457
Study 16765851 — intervention group
Group type: EXPERIMENTAL
Intervention: Johrei healing method
Number of subjects: 33
Study 16765851 — intervention group
Group type: COMPARATOR
Intervention: Control resting condition (10 min without Johrei)
Number of subjects: 33
Study 12677732 — intervention group
Group type: EXPERIMENTAL
Intervention: Taste strips impregnated with different taste solutions (four concentrations each for sweet, sour, salty, and bitter)
Number of subjects: 69
Study 12677732 — intervention group
Group type: EXPERIMENTAL
Intervention: Taste strips
Number of subjects: 69
Study 11130155 — intervention group
Group type: EXPERIMENTAL
Intervention: On-campus bar
Number of subjects: 221
Study 11130155 — intervention group
Group type: COMPARATOR
Intervention: Laboratory
Number of subjects: 221
Study 11130155 — intervention group
Group type: EXPERIMENTAL
Intervention: Just enough to begin to feel intoxicated
Number of subjects: 221
Study 11130155 — intervention group
Group type: EXPERIMENTAL
Intervention: Too much to drink
Number of subjects: 221
Study 9268956 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg.kg-1 dose of powdered aspirin
Number of subjects: 19
Study 9268956 — intervention group
Group type: COMPARATOR
Intervention: Placebo (water and Kool-Aid mixture without aspirin)
Number of subjects: 19
Study 9268956 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal cycle ergometry test
Number of subjects: 19
Study 9268956 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-s cycling bouts at various power outputs (100, 150, 200, and 250 W)
Number of subjects: 19
Study 1414219 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxcarbazepine (OXC) with Erythromycin (ERY)
Number of subjects: 8
Study 1414219 — intervention group
Group type: COMPARATOR
Intervention: Oxcarbazepine (OXC) without Erythromycin (ERY)
Number of subjects: 8
Study 3973293 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-dimensional echocardiography
Number of subjects: 125
Study 31693128 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed HPV self-sampling kit
Number of subjects: 19851
Study 31693128 — intervention group
Group type: COMPARATOR
Intervention: Usual care (annual patient reminders and ad hoc outreach)
Number of subjects: 19851
Study 29377984 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-lead electrical delay (IED) ≥100 ms
Number of subjects: 160
Study 29377984 — intervention group
Group type: COMPARATOR
Intervention: Inter-lead electrical delay (IED) <100 ms
Number of subjects: 160
Study 29377984 — intervention group
Group type: EXPERIMENTAL
Intervention: IED categorized by tertiles
Number of subjects: 160
Study 27898699 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended 5-month Seasonal Malaria Chemoprevention (SMC) programme
Number of subjects: 21
Study 27898699 — intervention group
Group type: EXPERIMENTAL
Intervention: Future delivery of SMC by trained community health workers (CHWs)
Number of subjects: 21
Study 27898699 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers' physical access to SMC medication
Number of subjects: 21
Study 24668314 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy (NIRS)
Number of subjects: 10
Study 24668314 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular occlusion testing (VOT)
Number of subjects: 10
Study 24668314 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Pain Inventory (BPI) and Disability of the Arm, Shoulder and Hand (DASH) questionnaires
Number of subjects: 10
Study 22734373 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate acupuncture of chronomedicine (group A)
Number of subjects: 50
Study 22734373 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture (group B)
Number of subjects: 50
Study 20128827 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant stability quotient (ISQ) measured in buccolingual direction
Number of subjects: 53
Study 20128827 — intervention group
Group type: EXPERIMENTAL
Intervention: Implant stability quotient (ISQ) measured in mesiodistal direction
Number of subjects: 53
Study 20128827 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher ISQ values
Number of subjects: 53
Study 20128827 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower ISQ values
Number of subjects: 53
Study 20128827 — intervention group
Group type: EXPERIMENTAL
Intervention: ISQ variation groups (variation of 3 or more vs <3)
Number of subjects: 53
Study 18387880 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational PowerPoint presentation for employees, minor environmental acoustical alterations, use of a Quest 261 Sound Detector/Controller for behavioral modification
Number of subjects: 0
Study 18387880 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 0
Study 11665796 — intervention group
Group type: EXPERIMENTAL
Intervention: 800,000 units of intravenous monteplase followed by rescue PTCA
Number of subjects: 164
Study 11665796 — intervention group
Group type: COMPARATOR
Intervention: Primary percutaneous transluminal coronary angioplasty (PTCA)
Number of subjects: 164
Study 11665796 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 164
Study 9628067 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-2 (IL-2) administered subcutaneously at a dosage of 9,000,000 U.I. b.i.d. for three days before surgery
Number of subjects: 13
Study 9628067 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 8166943 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg daily from mean gestational age of 17.7 weeks
Number of subjects: 47
Study 8166943 — intervention group
Group type: COMPARATOR
Intervention: Placebo from mean gestational age of 18 weeks
Number of subjects: 47
Study 8166943 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 100 mg daily
Number of subjects: 47
Study 8166943 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study 3063048 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural clonidine 3 micrograms/kg
Number of subjects: 20
Study 3063048 — intervention group
Group type: COMPARATOR
Intervention: Epidural 0.9% saline (control)
Number of subjects: 20
Study 30998400 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging intervention (6 messages/week for 6 months)
Number of subjects: 822
Study 30998400 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care + 2 thank you messages/month)
Number of subjects: 822
Study 30998400 — intervention group
Group type: EXPERIMENTAL
Intervention: Text messaging intervention
Number of subjects: 822
Study 28337880 — intervention group
Group type: EXPERIMENTAL
Intervention: Etomidate anesthesia
Number of subjects: 120
Study 28337880 — intervention group
Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 120
Study 25539349 — intervention group
Group type: EXPERIMENTAL
Intervention: AlloDerm
Number of subjects: 128
Study 25539349 — intervention group
Group type: EXPERIMENTAL
Intervention: DermaMatrix
Number of subjects: 128
Study 23747824 — intervention group
Group type: EXPERIMENTAL
Intervention: Clearfil Tri-S Bond (C3S; Kuraray)
Number of subjects: 30
Study 23747824 — intervention group
Group type: EXPERIMENTAL
Intervention: G-Bond (GB; GC)
Number of subjects: 30
Study 22140531 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention for GPs and care facility staff
Number of subjects: 351
Study 22140531 — intervention group
Group type: EXPERIMENTAL
Intervention: Education intervention for GPs and care facility staff (post hoc analysis)
Number of subjects: 351
Study 19768649 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosfomycin (3 g single dose)
Number of subjects: 109
Study 19768649 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin-clavulanate (7-day regimen)
Number of subjects: 109
Study 17053340 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-exposure therapy (4 weeks)
Number of subjects: 10
Study 17053340 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control (3 months)
Number of subjects: 10
Study 17053340 — intervention group
Group type: COMPARATOR
Intervention: Matched control group (month 0)
Number of subjects: 10
Study 12721944 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV7
Number of subjects: 0
Study 12721944 — intervention group
Group type: COMPARATOR
Intervention: PPV23
Number of subjects: 0
Study 10719136 — intervention group
Group type: EXPERIMENTAL
Intervention: Two‐session psychosocial intervention
Number of subjects: 41
Study 10719136 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 41
Study 9332921 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (0.1 mg/kg per h)
Number of subjects: 71
Study 9332921 — intervention group
Group type: COMPARATOR
Intervention: Nitroglycerin (1 microgram/kg per min)
Number of subjects: 71
Study 8458248 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (CFX) plus amikacin (single daily doses)
Number of subjects: 144
Study 8458248 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (CFX) plus amikacin (divided in three doses)
Number of subjects: 144
Study 8458248 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime plus amikacin
Number of subjects: 144
Study 31999478 — intervention group
Group type: EXPERIMENTAL
Intervention: Faster insulin aspart
Number of subjects: 13
Study 31999478 — intervention group
Group type: COMPARATOR
Intervention: Standard insulin aspart
Number of subjects: 13
Study 30328674 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity-modulated proton therapy (IMPT)
Number of subjects: 24
Study 30328674 — intervention group
Group type: COMPARATOR
Intervention: Volumetric-modulated arc therapy (VMAT)
Number of subjects: 24
Study 28605557 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive management (target SBP < 140 mm Hg)
Number of subjects: 3233
Study 28605557 — intervention group
Group type: COMPARATOR
Intervention: Contemporaneous guideline‐recommended management (target SBP < 180 mm Hg)
Number of subjects: 3233
Study 26271344 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g metformin twice daily
Number of subjects: 37
Study 26271344 — intervention group
Group type: COMPARATOR
Intervention: Control (no metformin)
Number of subjects: 37
Study 24391225 — intervention group
Group type: EXPERIMENTAL
Intervention: 810nm diode laser
Number of subjects: 0
Study 24391225 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 0
Study 21414151 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoid and laryngeal movement during swallowing
Number of subjects: 28
Study 21414151 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced anterior hyoid displacement and abnormal correlation patterns
Number of subjects: 28
Study 21414151 — intervention group
Group type: COMPARATOR
Intervention: Cervical spine length
Number of subjects: 28
Study 21414151 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoid displacement
Number of subjects: 28
Study 21414151 — intervention group
Group type: EXPERIMENTAL
Intervention: Arytenoid displacement
Number of subjects: 28
Study 21414151 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive hyoid‐laryngeal movement correlations
Number of subjects: 28
Study 18696172 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation Training (RT)
Number of subjects: 141
Study 18696172 — intervention group
Group type: EXPERIMENTAL
Intervention: Written Emotional Disclosure (WED)
Number of subjects: 141
Study 18696172 — intervention group
Group type: COMPARATOR
Intervention: Neutral Writing Control
Number of subjects: 141
Study 16861080 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoREZ with master cones and passive application of accessory cones
Number of subjects: 0
Study 16861080 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of Clearfil Liner Bond 2V before EndoREZ and gutta‐percha condensation
Number of subjects: 0
Study 16861080 — intervention group
Group type: COMPARATOR
Intervention: Warm vertical compaction with AH Plus
Number of subjects: 0
Study 16861080 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoREZ with 12 mm apical resection
Number of subjects: 0
Study 12723823 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearable continuous-read precision phase-change thermometer (WCPPT)
Number of subjects: 29
Study 12723823 — intervention group
Group type: COMPARATOR
Intervention: Glass-mercury thermometer (GMA)
Number of subjects: 29
Study 11243631 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-CD3 antibodies (1 microg/ml)
Number of subjects: 0
Study 11243631 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytohemagglutinin (10 microg/ml)
Number of subjects: 0
Study 11243631 — intervention group
Group type: EXPERIMENTAL
Intervention: Staphylococcal enterotoxin A (0.1 microg/ml)
Number of subjects: 0
Study 11243631 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuberculin purified protein derivative (10 microg/ml)
Number of subjects: 0
Study 11243631 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed lymphocyte reaction
Number of subjects: 0
Study 9194443 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide
Number of subjects: 40
Study 9194443 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 40
Study 8455962 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular ultrasonic stimulation
Number of subjects: 0
Study 8455962 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracutaneous electrical stimulation
Number of subjects: 0
Study 8455962 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral dose of pethidine
Number of subjects: 0
Study 8455962 — intervention group
Group type: COMPARATOR
Intervention: Electrical stimulation
Number of subjects: 0
Study 8455962 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound stimulation
Number of subjects: 0
Study 3513569 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (10 mg/day) for 4 months
Number of subjects: 10
Study 3513569 — intervention group
Group type: COMPARATOR
Intervention: Control medications
Number of subjects: 10
Study 3513569 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid treatment
Number of subjects: 10